The Medicines and Healthcare products Regulatory Agency (MHRA) is hoping to address a critical regulatory issue for medical ...

Politico has said that O'Neill and HHS General Counsel Mike Stuart are leaving their current roles as part of a broader shake ...

One of the beneficiaries of the FDA's national priority vouchers, Disc Medicine, has had its marketing application turned ...

Originally developed as a more-potent follow-up to Roche's long-established CD20-directed antibody Rituxan (rituximab) for ...

Recent developments in the biopharma AI world include an alliance between Thermo and Datavant, plus news from Insilico, ...

Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem – will seek to share a taste of those insights gleaned during that five-day press trip. It is hoped that some small part of ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

However, the opioid pathway, a heavily studied physiologic pathway inextricably intertwined with behaviour and reward, rarely receives attention within psychiatric practice. Although the opioid system ...

Storage specialist appoints new chief executive. Astoriom, a UK specialist in R&D sample storage, named Will Edwards as CEO. Edwards brings extensive international leadership experience in the storage ...

Shares in BridgeBio were ticking up today after it revealed data from its phase 3 trial of infigratinib in achondroplasia, ...

In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...

Results from the phase 2b PROCEED trial of intravenous bocunebart (also known as Lu AG09222) showed that the drug was able to ...